Page 141 - Clinical Small Animal Internal Medicine
P. 141

13  Hypoglycemia in Patients without Diabetes Mellitus  109

               intravenous glucose administration and anticonvulsant   has been steadily rising over the last few years, with a
  VetBooks.ir  therapy. The owners of these dogs chose euthanasia   resultant surge in xylitol cases reported to the APCC.
               because of poor response to therapy and poor prognosis.
               Blood was cultured from one dog using a special enrich­
                                                                  In laboratory experiments, xylitol directly stimulates
               ment PCR media to rule in or rule out an infection   Clinical Signs and Laboratory Abnormalities
               caused by a fastidious bacteria;  Bartonella hensalae   insulin synthesis and secretion within 30 minutes after
               was amplified and sequenced from this dog’s blood. In   ingestion. However, in clinical cases, the onset of clinical
               the other dog,  Bartonella kohlerae was amplified and   signs varies based on the form of xylitol used in the prod­
               sequenced retrospectively from paraffin‐embedded   uct ingested. The powder used in candies and mints is
                 tissue. Despite isolating Bartonella spp. from both dogs,   absorbed quickly and signs can be seen in 30 minutes.
               it is unclear whether B. hensalae and B. kohlerae contrib­  Gum must be chewed to release the xylitol. If the gum is
               uted to the pathogenesis of this unusual and rare   swallowed whole it leaches into the stomach, and the
                 hypoglycemic syndrome. That said, persistent hyperin­  onset of clinical signs can be delayed 8–18 hours.
               sulinemic hypoglycemic syndrome should be suspected   Vomiting is often the first symptom. Clinical signs can
               in any young dog with hypoglycemia refractory to intra­  include ataxia, depression, dilated pupils, and seizures
               venous  glucose.  Moreover,  until  more  is  known  about   (related to hypoglycemia), and lethargy, inappetence,
               the cause of this syndrome, testing and treating   vomiting, and diarrhea (related to liver failure).
               for  Bartonella should be a diagnostic and therapeutic   Laboratory abnormalities initially include hyperinsuline­
               consideration.                                     mia, hypoglycemia, hypophosphatemia, hypokalemia,
                                                                  and increased AST and ALT concentrations. Dogs that
                                                                  do not exhibit hypoglycemia immediately after ingestion
               Xylitol Toxicity
                                                                  of xylitol may still develop acute liver failure. These dogs
               Xylitol exposure, even in small amounts, can cause hypo­  may develop severe signs 24–72 hours later.
               glycemia and severe liver damage in dogs. Xylitol is a 5‐
               carbon sugar alcohol that is used primarily as an artificial   Diagnosis
               sweetener that has less than two‐thirds of the calories of   The diagnosis of xylitol toxicity is made by history of
               most sugars. The two major sources of xylitol exposure   exposure, clinical signs, and serum biochemical abnor­
               are food and dental or medical products. Initially, expo­  malities consistent with xylitol poisoning. Because the
               sure  to xylitol  in dogs was from “sugar‐free”  chewing   serum half‐life of xylitol is about two minutes and there
               gums. However, with demands from human diabetic    is rapid progression of the toxic effect, testing for xylitol
               patients, particularly because of the popularity of Atkins‐  in the blood is not realistic.
               like “low‐carb” diets, many foods now contain xylitol. A
               large number of low‐carbohydrate foods, including   Treatment and Monitoring
               breads, candies, gums, and deserts, have xylitol as the   Blood glucose levels should be determined initially and
               sweetener of choice. Xylitol has a wide margin of safety   monitored at least every four hours for 24 hours or
               in mammals with the exception of dogs. Oral exposures   longer, as indicated. Liver enzyme levels and prothrom­
               as low as 0.1 mg/kg have induced hypoglycemia in the   bin time/partial thromboplastin time (PT/PTT) should
               dog, and levels of 0.5 mg/kg have resulted in hepatotoxic­  be monitored every 24 hours for 48–72 hours. It is not
               ity in some dogs. For example, one piece of Trident gum   uncommon to have a transient elevation in ALT (300–
               contains 0.22 g of xylitol and the popular breath mint Ice   800) very quickly after ingestion. Electrolyte status and
               Breakers contains 1 g of xylitol per piece and therefore,   packed cell volume (PCV) should also be monitored
               nine pieces of Trident or two Ice Breaker pieces could   regularly.
               potentially cause xylitol toxicity in a 20 kg dog. The lit­
               erature reports no cases of xylitol toxicity in cats.  ●   There is no antidote for xylitol toxicity.
                                                                     Induce emesis if the xylitol ingestion is recent.
                                                                  ●
               Prevalence                                         ●   Use of activated charcoal is of limited efficacy with
               Recently, there has been a rapid increase in the number   xylitol because it is not effective at binding xylitol.
               of products containing xylitol. According to the ASPCA   ●   IV fluid support: important to restore or maintain
               Animal Poison Control Center (APCC), the number of   hydration, treat hypoglycemia, and prevent or treat
               reported xylitol exposures in dogs has been increasing   disseminated intravascular coagulation (DIC). Patients
               steadily and exponentially over the past few years. In   with normal blood glucose levels should receive a 2.5%
               2007, theAPCC began to log xylitol cases. That year, the   dextrose solution.
               center received 1764 calls about xylitol. In 2012, the fig­  ●   Hypoglycemia caused by xylitol toxicity is usually
               ure was 3184. The number of products containing xylitol   responsive to IV dextrose solutions. Refractory cases
   136   137   138   139   140   141   142   143   144   145   146